Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AIRE	"APECED, APS1, PGA1"	ENSG00000160224	"Autoimmune regulator"	O43918	21	44285838-44298648	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 5.3;lymphoid tissue: 8.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;NTERA-2: 1.1;U-87 MG: 1.3"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 6.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038267	Uncertain									"HPA038267: AB_10697247"	"unprognostic (3.24e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.69e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.29e-7)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.57e-2)"	0.3	0.3	1.4	0.9	3.4	1.3	1.2	0.2	3.5	0.5	0.3	1.0	0.0	0.0	0.4	0.8	0.4	0.3	0.2	0.5	1.0	5.3	0.4	0.2	0.6	2.3	1.1	1.8	0.3	1.1	0.0	0.3	0.1	3.6	0.4	0.0	0.2	2.2	1.2	0.5	0.3	0.8	0.1	1.3	0.5	0.8	0.4	0.4	8.3	0.3	0.0	0.2	0.2	0.2	0.4	0.3	1.3	0.3	0.3	0.6	0.2	0.1	0.0	0.4	0.1	0.3	0.2	0.0	0.5	0.0	0.0	0.1	0.3	0.3	0.1	0.3	0.0	0.3	0.2	0.6	0.0	0.3	0.3	0.0	0.6	0.3	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.3	0.0	0.3	1.1	0.0	0.1	0.0	0.5	0.0	0.7	0.3	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.3	0.3	0.3	0.8	0.0	0.3	1.3	0.2	0.3	0.8	0.3	0.1	0.5	0.3	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.6	1.3	0.3	0.2	0.3	0.2	0.2	1.4	3.4	0.2	3.5	1.0	5.3	1.1	1.8	3.6	0.4
DEAF1	"NUDR, SPN, ZMYND5"	ENSG00000177030	"DEAF1, transcription factor"	O75398	11	644233-706715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030302	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"	"Intracellular and membrane"			Nucleoplasm	"Nucleoli fibrillar center"	"HPA030302: "	"unprognostic (1.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.90e-2)"	"prognostic unfavourable (9.70e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.15e-2)"	4.8	5.9	36.1	6.5	19.9	4.5	16.9	19.4	26.2	5.4	4.3	5.3	5.2	4.8	7.5	6.3	6.8	9.8	6.0	8.3	30.2	15.7	4.5	2.8	5.3	4.4	18.3	3.4	6.0	13.2	5.9	14.5	5.2	9.7	6.7	2.2	3.6	11.8	4.7	7.8	6.6	4.0	7.2	8.1	4.0	7.2	5.7	9.8	15.2	12.0	2.7	5.3	7.0	20.3	1.2	4.4	3.3	3.0	3.5	5.9	1.6	7.3	4.5	7.3	3.9	7.1	9.4	5.7	5.4	7.1	11.7	8.5	4.8	6.3	2.1	6.0	5.4	4.9	7.0	5.0	1.7	9.0	41.4	4.9	2.5	3.7	12.9	10.8	8.0	7.9	6.9	2.1	5.9	9.2	10.9	8.7	4.4	3.7	4.0	9.9	17.0	9.5	9.9	2.5	8.1	8.2	0.9	10.4	10.9	4.0	5.9	3.9	3.6	3.1	10.6	3.8	2.1	1.6	4.7	9.6	3.5	3.8	4.4	7.2	7.5	0.0	3.0	3.3	2.4	1.7	2.6	1.2	4.7	2.7	4.4	0.8	5.9	3.2	1.8	3.5	1.9	0.5	1.7	1.6	36.1	19.9	19.4	26.2	30.2	15.7	18.3	3.4	9.7	9.8
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668732-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044811: AB_10959666, HPA052975: "	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favourable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	8.3	6.6	8.0	14.0	6.5	21.1	8.7	13.5	9.0	8.8	8.0	8.4	6.4	5.4	10.9	8.0	10.4	8.5	8.0	6.8	7.8	4.9	6.6	7.3	8.7	11.3	5.8	7.0	12.1	7.5	8.6	8.8	16.4	5.8	7.2	8.4	8.0	7.4	6.8	10.3	9.3	8.6	9.1	6.3	11.5	7.4	11.4	6.4	25.3	7.5	7.0	14.1	7.9	12.4	10.8	9.7	14.4	12.7	10.6	12.8	6.3	9.2	6.7	11.4	10.3	3.8	7.0	8.1	9.9	7.2	6.4	9.6	2.1	7.4	17.0	5.2	9.2	3.6	10.1	7.7	8.4	19.4	6.2	15.9	7.0	4.1	5.7	13.1	8.2	5.6	5.5	15.5	10.1	8.8	9.5	13.8	7.7	8.1	8.2	4.4	15.2	4.5	5.5	7.8	7.9	4.8	7.6	8.4	6.9	9.4	6.4	6.4	4.9	6.8	8.8	4.4	10.6	7.5	13.3	6.1	10.4	9.6	5.3	12.3	6.9	10.0	8.2	14.4	11.1	10.2	8.4	6.6	10.6	12.8	9.7	10.8	8.8	9.3	11.8	10.6	12.7	7.2	8.9	6.3	8.0	6.5	13.5	9.0	7.8	4.9	5.8	7.0	5.8	6.4
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: "	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	9.3	8.2	7.4	9.0	9.8	29.8	8.4	13.5	11.5	8.7	10.5	7.7	6.9	9.6	10.6	6.1	10.0	11.0	9.5	7.4	8.1	6.2	7.7	9.3	8.7	11.5	6.0	6.5	11.5	17.6	9.6	9.5	14.5	7.2	9.9	5.1	9.8	16.0	7.5	10.1	10.0	11.0	10.3	7.1	12.1	8.8	18.8	5.7	24.7	18.0	9.5	10.4	9.2	13.8	3.0	2.6	4.4	5.6	1.9	4.5	2.2	10.7	6.6	8.1	7.0	3.9	3.6	10.8	7.5	4.8	12.1	6.4	20.4	8.0	8.6	7.9	6.5	15.4	6.3	11.0	5.4	4.6	7.1	6.6	9.6	9.8	5.3	6.3	11.0	5.2	10.5	7.8	9.8	5.3	9.7	6.2	4.2	11.6	15.3	13.8	5.8	10.7	16.7	8.3	7.9	4.9	9.6	12.2	10.0	13.5	12.0	7.8	14.6	10.4	6.5	13.3	7.3	7.9	8.2	11.9	9.8	13.6	8.0	5.9	8.6	0.0	1.9	3.2	4.5	2.6	4.3	2.1	4.0	3.9	2.1	3.0	4.5	3.9	4.4	1.9	5.6	2.6	2.7	2.2	7.4	9.8	13.5	11.5	8.1	6.2	6.0	6.5	7.2	5.7
MEF2A	"RSRFC4, RSRFC9"	ENSG00000068305	"Myocyte enhancer factor 2A"	Q02078	15	99565417-99716466	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004499, HPA046597"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB004499: AB_627921, HPA046597: "	"unprognostic (1.89e-1)"	"unprognostic (8.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (6.93e-4)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-3)"	28.9	17.4	17.4	19.1	24.3	12.0	20.1	22.9	31.6	21.9	19.7	20.1	18.2	9.5	30.5	24.7	16.6	20.5	16.6	62.0	14.9	12.7	18.8	17.5	26.0	16.7	14.0	21.9	23.0	11.7	32.0	10.2	18.8	16.1	19.9	11.4	14.5	15.5	18.4	46.1	38.4	16.3	31.2	23.6	22.2	16.3	10.7	15.8	17.6	15.2	19.6	17.3	25.2	15.9	12.8	10.7	11.3	14.2	5.6	4.5	4.3	8.7	5.0	8.4	4.2	10.7	13.8	4.2	8.9	20.5	7.3	10.0	5.1	12.2	11.0	12.6	19.0	9.6	8.5	7.0	9.6	7.4	12.5	22.1	11.1	4.6	18.4	8.7	10.9	9.2	11.8	9.8	20.4	13.3	7.8	21.1	13.6	3.6	14.3	13.0	4.6	7.3	21.0	18.4	8.9	15.1	12.4	5.4	7.6	13.5	5.9	25.0	5.5	8.0	21.7	20.5	11.2	10.1	10.7	11.5	13.1	24.0	14.3	9.7	19.4	6.2	10.3	11.3	3.4	12.8	2.9	12.8	3.2	3.0	10.7	10.4	4.5	3.4	10.2	5.6	14.2	6.6	2.1	4.3	17.4	24.3	22.9	31.6	14.9	12.7	14.0	21.9	16.1	15.8
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145568-19170289	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"lymphoid tissue: 81.2"	"Group enriched"	"Detected in some"	12	"Daudi: 49.8;U-266/70: 50.0;U-698: 65.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	2.0	1.0	0.8	81.2	1.2	1.4	1.9	0.6	1.4	2.7	3.0	0.9	0.6	1.5	2.2	1.1	1.5	2.3	2.2	1.9	1.0	0.6	1.8	2.9	2.0	32.3	1.1	0.9	3.7	0.8	0.8	2.1	0.8	1.0	3.7	1.0	1.8	3.5	1.1	1.4	2.3	3.1	1.1	1.2	6.7	1.7	1.7	0.8	1.6	3.0	3.5	58.7	1.9	2.9	0.1	0.2	1.1	0.9	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	49.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.3	0.0	0.9	0.4	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.4	0.5	0.1	50.0	4.6	65.8	0.1	0.3	0.0	0.0	0.9	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.4	1.0	0.6	1.1	0.9	1.0	0.8
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;HEL: 52.3;Karpas-707: 28.8;REH: 59.6;WM-115: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	5	"B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5"	"Group enriched"	"Detected in many"	7	"amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3"	"Group enriched"	"Detected in all"	4	"amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB068196: , CAB068197: , HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	13.9	10.8	17.0	15.0	26.7	3.8	10.7	4.3	52.8	8.2	6.8	6.1	1.5	2.8	10.9	5.4	5.0	6.4	9.8	11.2	11.1	6.8	4.5	4.0	8.3	19.3	6.6	28.0	12.3	2.9	5.2	6.5	14.8	4.8	7.1	5.7	4.6	6.6	6.6	154.8	3.9	7.4	10.8	8.3	16.0	4.5	3.6	4.4	1.6	9.6	3.5	24.0	8.9	5.8	48.2	23.8	5.8	19.5	4.0	0.1	7.2	0.3	0.0	1.7	0.0	1.8	1.1	0.0	0.5	1.0	0.0	0.2	0.0	0.2	23.7	0.1	2.7	0.7	2.2	2.1	0.0	7.2	2.9	52.3	3.1	0.0	0.6	2.3	0.1	5.2	0.0	0.0	0.0	8.2	2.7	28.8	2.1	0.0	0.0	0.0	0.5	1.9	59.6	15.0	11.4	0.0	0.2	0.0	2.0	0.0	0.1	6.9	0.0	13.3	9.4	1.3	0.2	0.1	1.2	21.9	2.5	14.3	0.3	16.2	34.1	0.1	17.2	0.0	0.0	19.5	0.0	32.6	0.0	0.0	22.3	48.2	0.0	0.0	5.8	4.0	15.9	23.8	0.1	7.2	17.0	26.7	4.3	52.8	11.1	6.8	6.6	28.0	4.8	4.4
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500828	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.8"	"Cell line enhanced"	"Detected in all"		"THP-1: 53.9;U-266/70: 47.4;U-266/84: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	18.1	19.6	14.9	15.7	27.5	47.6	15.5	27.0	40.3	23.8	21.1	12.1	10.5	11.0	28.6	12.9	13.8	19.5	16.6	26.3	11.8	9.6	10.4	10.6	20.0	13.9	8.6	21.1	26.7	22.4	21.4	15.0	16.2	11.6	17.2	10.6	22.3	11.3	18.8	97.8	17.5	14.8	22.0	8.4	17.2	16.1	9.9	9.9	17.2	14.7	19.4	15.6	21.9	19.3	1.7	8.5	8.1	2.0	1.5	2.3	0.8	4.5	8.5	1.8	2.7	4.3	6.0	2.7	6.0	7.8	3.2	3.4	2.7	6.2	10.6	6.9	8.0	4.5	2.1	3.4	1.9	14.4	2.8	2.5	10.4	1.5	5.3	6.2	8.4	6.7	5.8	5.5	7.5	6.0	1.8	18.7	5.0	4.3	4.1	14.3	2.6	4.3	20.4	3.9	12.2	2.7	2.2	2.9	4.6	5.8	12.6	10.0	3.4	53.9	10.0	7.5	7.1	5.5	4.4	47.4	48.8	20.3	6.4	4.9	4.0	1.3	2.0	2.3	1.9	1.1	2.3	1.7	1.4	1.7	1.4	1.7	0.7	1.3	8.1	1.5	1.9	8.5	1.6	0.8	14.9	27.5	27.0	40.3	11.8	9.6	8.6	21.1	11.6	9.9
SP100		ENSG00000067066	"SP100 nuclear antigen"	P23497	2	230415942-230544090	"Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA016707, HPA017384"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA016707: AB_1857398, HPA017384: AB_1857399"	"unprognostic (8.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.25e-2)"	39.7	27.7	7.0	44.0	12.9	56.8	33.4	3.4	9.4	25.6	28.3	5.5	19.1	15.3	18.9	20.5	22.5	16.1	20.3	32.3	7.1	5.3	21.7	24.8	36.0	48.5	13.0	4.0	23.8	19.9	1.8	13.7	25.1	10.9	24.0	12.4	13.9	23.4	17.6	14.6	17.3	35.4	20.2	15.6	52.2	18.6	9.8	10.6	25.9	31.6	17.8	37.4	27.0	34.7	44.1	17.4	75.6	25.2	30.8	33.2	26.1	13.3	4.0	0.2	1.8	20.8	33.8	3.2	17.4	39.1	40.5	65.4	2.4	15.8	6.2	14.1	18.8	6.6	0.2	16.6	29.7	14.8	0.5	10.6	6.9	5.3	30.1	12.5	14.6	27.7	9.8	19.4	17.6	30.5	5.4	10.2	15.4	3.6	7.8	13.3	0.6	6.4	5.9	9.5	4.3	11.5	11.4	0.1	0.2	6.9	2.2	29.9	2.1	13.0	36.7	19.6	5.2	11.9	10.0	12.8	4.1	13.9	18.7	13.7	9.4	31.8	22.5	28.6	33.2	19.2	26.3	38.9	32.3	28.5	16.8	44.1	31.0	27.3	75.6	30.8	25.2	17.4	29.1	26.1	7.0	12.9	3.4	9.4	7.1	5.3	13.0	4.0	10.9	10.6
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230167293-230225729	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 65.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA047036, HPA058554"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA047036: AB_10963065, HPA058554: "	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	21.4	8.9	6.5	29.9	12.1	17.6	12.3	3.1	7.5	10.2	8.9	11.6	3.2	7.6	13.5	8.0	11.1	8.1	11.7	8.6	6.0	5.7	10.0	10.4	14.6	43.4	10.7	4.6	12.7	10.0	8.9	13.0	11.2	8.9	12.2	9.4	9.3	10.3	5.4	8.0	7.9	18.6	9.5	12.7	45.2	9.2	4.0	10.3	32.7	8.4	5.7	35.1	14.3	13.2	36.0	21.3	65.9	31.7	13.2	16.5	10.4	3.1	1.7	1.0	1.8	5.7	9.5	3.4	6.0	12.1	28.4	40.7	0.0	5.0	13.6	5.6	6.1	2.0	3.8	9.2	10.7	12.2	2.3	5.7	2.6	3.4	5.9	8.3	6.9	13.4	4.6	8.3	11.9	9.8	2.0	4.9	8.0	1.9	12.4	16.2	3.5	2.0	7.8	10.1	5.1	22.8	4.3	0.2	2.3	2.2	4.9	12.1	3.7	7.1	7.2	5.2	3.2	1.2	2.9	5.3	1.8	6.8	5.7	7.9	4.2	18.6	12.0	29.1	14.7	20.4	12.6	36.0	14.1	12.9	10.6	34.5	14.6	15.2	65.9	13.2	31.7	21.3	16.5	10.4	6.5	12.1	3.1	7.5	6.0	5.7	10.7	4.6	8.9	10.3
SP140	"LYSP100-A, LYSP100-B"	ENSG00000079263	"SP140 nuclear body protein"	Q13342	2	230203110-230313215	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.2;lymphoid tissue: 46.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.6;HDLM-2: 29.4;Karpas-707: 14.7;RPMI-8226: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 36.2"	"Low lineage specificity"	"Detected in all"											"HPA006162, HPA067493"	Enhanced		Approved	"Nucleoli fibrillar center,Mitochondria"				"Nucleoli fibrillar center"	Mitochondria	"HPA006162: AB_1857403, HPA067493: "	"unprognostic (8.15e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-3)"	"unprognostic (5.72e-4)"	"unprognostic (5.66e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.20e-9)"	"unprognostic (9.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.30e-3)"	1.9	0.8	0.9	39.1	1.1	2.9	1.1	0.5	0.7	0.7	2.3	0.5	0.0	1.4	0.6	0.9	3.5	0.8	1.4	0.8	0.9	1.0	1.1	1.1	6.3	26.9	1.4	0.0	0.7	0.4	0.0	0.9	0.6	0.6	1.0	2.0	1.0	8.9	0.1	0.3	0.7	13.1	0.3	2.0	34.9	2.3	1.3	0.7	4.0	1.3	1.7	46.8	4.8	0.9	36.2	3.0	12.6	3.6	5.1	10.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	17.6	0.0	0.0	0.0	0.0	0.0	1.1	29.4	0.0	0.0	0.0	0.3	0.1	2.5	0.1	0.3	0.0	0.3	0.4	0.0	0.0	14.7	0.3	0.0	0.0	0.8	0.8	0.0	0.0	1.6	9.1	5.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.8	0.0	0.0	5.4	2.2	0.6	1.3	0.4	0.0	0.0	1.3	4.1	9.0	2.6	10.0	36.2	9.0	9.7	3.0	25.1	4.6	6.1	12.6	5.1	3.6	0.2	7.8	3.6	0.9	1.1	0.5	0.7	0.9	1.0	1.4	0.0	0.6	0.7
SP140L		ENSG00000185404	"SP140 nuclear body protein like"	Q9H930	2	230327184-230403732	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA055864	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA055864: "	"unprognostic (1.44e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (5.09e-10)"	"unprognostic (9.15e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-3)"	11.0	10.5	2.2	24.3	4.6	9.6	9.3	1.0	2.8	11.2	10.0	4.3	8.7	8.5	12.5	12.0	8.4	7.7	9.7	6.0	3.3	2.2	7.7	14.5	12.3	19.3	4.8	1.4	12.3	5.1	1.9	6.1	10.8	4.8	9.1	7.5	5.1	16.0	12.5	5.4	3.5	16.2	9.4	6.7	25.0	6.8	2.8	4.3	15.7	6.3	6.4	22.7	10.5	16.0	21.0	5.1	11.2	7.1	14.5	13.4	6.0	7.7	1.4	1.8	5.6	9.7	10.6	10.2	11.4	13.2	9.6	15.3	0.8	8.9	5.8	12.0	8.9	1.4	0.0	8.3	15.8	15.3	0.0	10.4	6.1	5.7	18.0	8.5	11.9	8.7	4.5	13.9	9.3	14.0	2.5	5.5	17.3	4.2	12.6	11.9	6.4	4.0	4.4	17.0	4.6	8.7	9.7	0.3	1.7	2.7	5.7	6.4	8.5	9.1	15.3	8.6	6.3	4.8	8.7	8.2	5.0	8.4	11.3	8.7	14.9	11.2	4.9	2.4	10.4	6.5	12.5	16.9	9.5	8.3	5.1	21.0	13.4	12.0	5.0	14.5	7.1	2.1	5.8	6.0	2.2	4.6	1.0	2.8	3.3	2.2	4.8	1.4	4.8	4.3
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171299-43181507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	17.7	8.1	10.7	15.6	12.3	14.1	12.9	11.6	14.5	24.9	38.1	10.6	17.9	8.1	35.3	14.9	28.2	24.8	23.7	30.6	9.4	6.5	10.5	11.3	13.9	11.8	7.8	6.2	25.6	13.1	13.8	10.1	14.1	7.5	26.9	9.4	15.4	8.7	29.9	29.7	10.2	16.8	47.9	5.4	18.2	20.8	10.0	8.1	16.1	14.9	14.6	13.2	36.0	17.7	1.9	3.7	4.7	2.9	1.1	3.1	1.0	17.2	6.9	16.1	10.6	9.5	7.9	23.7	15.8	13.1	13.7	8.5	18.4	5.1	21.9	14.5	16.8	14.0	16.3	13.9	12.2	24.1	16.0	19.8	13.6	18.1	18.2	18.5	24.1	13.4	15.3	21.1	15.6	11.4	14.0	17.2	10.3	18.6	22.7	16.2	11.2	8.5	17.5	16.4	7.8	10.0	11.2	9.5	8.6	12.9	9.9	15.6	10.1	34.4	13.8	16.3	12.5	15.7	27.0	12.0	9.9	36.7	10.2	13.3	10.9	1.7	1.7	2.9	3.1	2.9	2.5	1.9	1.8	2.3	1.8	1.9	1.4	2.4	4.7	1.1	2.3	3.7	2.1	1.0	10.7	12.3	11.6	14.5	9.4	6.5	7.8	6.2	7.5	8.1